Digital Media briefs

Share this article:
Merck launched Vree for Diabetes 2.0, a mobile app for type 2 diabetes patients aimed at helping them track their blood sugar, medications, nutritional intake and activity level, with features including progress charts and live reminders. Unlike rival Sanofi's GoMeals, Merck said Vree for Diabetes lets patients store a wide variety of data in one place and allows them to create reports for discussion with healthcare providers.  

Text4baby, J&J's mobile pregnancy education service, hit the 100,000 subscriber mark. PR shop Hill & Knowlton said the program has also seen 650-plus placements and 75 million impressions following a campaign targeting third-party supporters, a celebrity PSA and a media outreach campaign aimed at tackling the high infant mortality and premature birth rates in the US.

Physicians Interactive named Brett Miller president of its healthcare professional division and its mobile division, Skyscape. The shop, specializing in mobile clinical information for physicians, also named Sandeep Shah chief content officer.

Smartphone users now represent one in four subscribers, comScore reported—a sharp jump from one in 10 just two years ago.
Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?